The Effect of Certain Hydrogenated Alkaloids of Ergot on Glaucoma*
- 1 October 1950
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 33 (10) , 1551-1554
- https://doi.org/10.1016/0002-9394(50)91215-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- ESSENTIAL HYPERTENSIONJAMA, 1949
- The treatment of arterial hypertension with dihydroergocornine methanesulfonate (D.H.O. 180): Ralph M. Tandowsky, M.D., and Fred V. Cerini, M.D., Los Angeles, Calif.American Heart Journal, 1949
- THE ACTION OF DIHYDROERGOCORNINE ON THE CIRCULATION WITH SPECIAL REFERENCE TO HYPERTENSIONThe Lancet, 1949
- Zur Analyse der Blutdruckwirkung der natürlichen und dihydrierten MutterkornalkaloideCellular and Molecular Life Sciences, 1949
- THE EFFECTS OF CERTAIN DIHYDROGENATED ALKALOIDS OF ERGOT IN HYPERTENSIVE PATIENTSThe Lancet Healthy Longevity, 1948
- The effect of ergot derivatives on the circulation in man with special reference to two new hydrogenated compounds (dihydroergotamine and dihydroergocornine)American Heart Journal, 1948
- Die Dihydroderivate der natürlichen linksdrehenden Mutterkornalkaloide. (9. Mitteilung über Mutterkornalkaloide)Helvetica Chimica Acta, 1943